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Özet
AMAÇ: Kronik lenfositik lösemi (KLL) en yaygın görülen yetişkin lösemi alt 
grubudur. Ancak paranazal sinüsler ve KLL arasındaki ilişkiyi araştıran az sayıda 
çalışma rapor edilmiştir. Bu çalışmada KLL’nin paranazal belirtilerini ve KLL has-
talarının nazal mukozalarında Nuclear factor-ĸB (NF-kB) ve Tumor necrosis factor 
(TNF-α) salınımını saptamayı amaçlandı.
GEREÇ VE YÖNTEMLER: Bu çalışma 40 hastayı içeren bir klinik çalışma olarak 
yapılmıştır. Grup KLL (n=20) herhangi bir tedavi almamış hematoloji kliniği ta-
rafından takip edilen erken evre KLL hastalarından oluşturuldu. Kontrol grubu 
(n=20) burun tıkanıklığı nedeniyle konka cerrahisi geçirmiş hastalardan oluş-
turuldu. Tüm hastaların paranazal sinus tomografileri çekilip Lund Mackay sis-
temine gore skorlandı ve sinüzit bulguları kaydedildi. Tüm hastaların alt konka 
başından alınan biyopsi materyalleri, NF-kB and TNF-α primer antikorları ile im-
münohistokimyasal olarak boyandı.
BULGULAR: İki grup arasında NF-κB (p=0.716) ve TNF-α (p=1.000) boyama 
skorlarına göre istatistiksel olarak anlamlı farklılık yoktu. Lund-Mackay skoru 
(p=0.004) kontrol grubuna göre KLLgrubunda anlamlı olarak daha yüksek bu-
lundu. KLL grubunda en yaygın tanı maksiler sinüzit (n=8) iken, 14 hastada farklı 
lokalizasyonlarda sinüzit bulguları saptandı.
SONUÇ: Bu çalışma erken evre KLL hastalarının akut rinosinüzite eğilimli oldu-
ğunu göstermektedir. Bununla birlikte, paranazal sinüsleri kapsayan inflamatu-
var süreçte NF-kB ve TNF-α bir role sahip olmadığını düşünmekteyiz.
ANAHTAR KELİMELER: Kronik lenfositik lösemi, NF-kB, TNF-α, Lund-Mackay 
skor, rinosinüzit
Abstract
OBJECTIVE: Chronic lymphocytic leukemia (CLL) is the most common adult 
leukemia. A few studies have been reported about the relationship between CLL 
and paranasal sinuses. We aimed to investigate the paranasal manifestations of 
CLL and to determine the expression of nuclear factor-ĸB (NF-kB) and tumor ne-
crosis factor (TNF-α) in the nasal mucosa in patients with CLL.
MATERIALS AND METHODS: This study was a clinical trial that involved 40 
patients. Group CLL (n=20) consisted of patients with early-stage CLL who were 
followed-up at the hematology clinic and who did not receive any treatment. 
The control group (n=20) consisted of patients who had undergone concha sur-
gery because of nasal obstruction. Paranasal sinus computer tomography scans 
of all patients were taken, they were scored on the basis of the Lund–Mackay 
system, and sinusitis findings were recorded. The biopsy material taken from the 
inferior concha head of all patients was immunohistochemically stained with 
primary antibodies against NF-kB and TNF-α.
RESULTS: There were no statistically significant differences between the two 
groups with respect to NF-κB (p=0.716) and TNF-α staining scores (p=1.000). 
The Lund–Mackay scores were significantly higher in the CLL group than in the 
control group (p=0.004). Fourteen patients had sinusitis at different locations, 
while the most common diagnosis was maxillary sinusitis (n=8) in the CLL group. 
CONCLUSION: This study showed that patients with early-stage CLL tend to 
have rhinosinusitis. However, NF-kB and TNF-α may not have a role in the inflam-
matory process involving the paranasal sinuses in patients with CLL.
KEYWORDS: Chronic lymphocytic leukemia, NF-Κb, TNF-α, Lund–Mackay 
score, rhinosinusitis
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Introduction
Chronic lymphocytic leukemia (CLL) is the most frequent leukemia of adults and is considered a malignancy of B lymphocyte (1). Al-
though spleen and lymph nodes are usually involved, head and neck region involvement is uncommon (2). Immunosuppression is 
commonly associated with CLL, and 25%–50% of patients with CLL die of respiratory or urinary tract infections (3).
It is known that nuclear factor-ĸB (NF-kB) transcription factor contributes to apoptosis and survival success of the cell by regulating 
the expression of more than 150 genes, including those encoding several cytokines, cell surface receptors, and molecules involved in 
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cell growth and differentiation, lymphocyte activation, and inflam-
mation (4). In many solid tumors and hematological malignancies, 
including CLL, NF-κB dimers are constitutively active. This constitu-
tive activation of NF-κB causes not only malignant transformation 
and tumor progression but also enables the tumor cells to evade im-
mune surveillance (5). In CLL, NF-κB has been found to be activated 
in the tissues to a variable degree, regardless of the disease stage or 
treatment status. Its activity seems to sustain tumor cell survival and 
enhance cell sensitivity to some inhibitor. In addition, NF-κB activa-
tion may suppress apoptosis in CLL cell lines (6).
Tumor necrosis factor (TNF-α) plays a role in the inflammation and 
immune response by inducing the inflammatory cytokines (7). Be-
sides, TNF-α significantly increases nuclear translocation of NF-Kb (8, 9). 
Elevated levels of TNF have been observed in patients with CLL, and 
an association with disease progression has been found (10).
Some inflammatory stimuli elicit biological responses through the 
activation of NF-κB and TNF-α signal cascades in inflammatory air-
way diseases such as rhinosinusitis and allergic rhinitis (10, 11).
A few studies have been reported about the relationship between 
CLL and paranasal sinuses (2, 12-14). We aimed to investigate the na-
sal manifestations of CLL and to determine the expression of NF-κB 
and TNF-α in the nasal mucosa in patients with CLL. 
Materials and Methods
The study was approved by the ethics committee of the university 
hospital. This retrospective study was conducted between January 
1, 2014, and October 1, 2014. A total of 40 patients were enrolled in 
the study. The patients were assigned to two groups: Group CLL and 
control group. Patients with CLL who were referred to our otolaryn-
gology outpatient clinic from a hematology clinic with upper respi-
ratory tract infection and/or suspected leukemia involvement were 
identified. Patients who had undergone paranasal sinus computed 
tomography were included in this study. Group CLL (n=20) consist-
ed of patients with early-stage CLL (binet A) who were followed-up 
at the hematology clinic and who did not receive any treatment. 
The control group (n=20) consisted of patients who had undergone 
concha surgery because of nasal obstruction. Patients with a known 
non-CLL malignancy and abnormal bleeding profile in the CLL group 
and patients who had previously undergone endoscopic sinus sur-
gery, recently received chronic rhinosinusitis (CRS) treatment, had 
one-sided nasal mass, and nasal polyposis in the control group were 
excluded from the study. Paranasal sinus computed tomography 
(PNS CT) scans of both groups were taken and scored on the basis 
of the grading system developed by Lund–Mackay (15). The sinus-
itis findings determined from PNS CT were recorded. The evaluations 
were made by a single physician (C.G).
Pathology slides consisting of the biopsy material taken from the 
inferior concha of all patients were evaluated. Then, the slides were 
subjected to immunohistochemical staining. Immunohistochemical 
staining was performed using DAKO Autostainer Universal Staining 
System (Autostainer Link 48 DAKO, Glostrup, Denmark). First, 4-μm 
sections were mounted on positive loaded glass slides. Then, the 
sections were deparaffinized with xylol and dehydrated by passing 
through ethyl alcohol series. Then, antigen retrieval was made in a 
thermostatic bath (PT Link) at 96°C (10 mM/L citrate buffer, pH 6) for 
40 min. The sections were incubated for 60 min with primary anti-
bodies against NF-κB/p50 (RB-1648; NeoMarkers, Fremont, CA, USA) 
and TNF-α (LS-B2123, LifeSpan, BioSciences, WA, USA). Using the 
streptavidin–biotin immunoperoxidase technique (K8000 Envision 
Flex, DAKO, Glostrup, Denmark), an automatized system was used. In 
order to ensure the color image, immunoreactions with diaminoben-
zidine tetrachloride (DAB) were displayed. For background staining, 
the sections were oppositely stained with hematoxylin. For dehydra-
tion, the sections were passed through alcohol series with increas-
ing strength and after clearing in xylol, they were lined with balsam. 
After staining, the sections were examined under light microscope 
(Olympus BX51, Tokyo, Japan) at 4×, 10×, 20×, and 40× magnifica-
tions by a single pathologist blind to the patient’s history and CT 
findings. In the highly stained areas (hot spots), minimum 200 cells 
were counted. They were scored as follows: staining <5%: 0; 5%–10%: 
1; 11%–20%: 2; >20%: 3.
SPSS 19 (SPSS Yazılım eğitim danışmanlık şirketi, Istanbul, Turkey) 
was used for calculations and statistical analysis. The Mann–Whitney 
U test was used to compare the Lund–Mackay scores. To analyze the 
categorical variables, a Chi-square test was used. Descriptive statis-
tics are presented as mean±standard deviation, median (25–75 per-
centile), and frequency (percentage). p values below 0.05 were con-
sidered statistically significant.
Results
Forty patients were included in this study. Twenty (50%) patients 
were female. The mean ages of the CLL and control group were 
68.90±6.711 years and 34.25±6.882 years, respectively. The base-
line characteristics of the CLL group are presented in Table 1. There 
were no statistically significant differences between the two groups 
with respect to NF-κB (p=0.716) and TNF-α (p=1.000) staining scores 
(Table 2). The median Lund–Mackay score in the CLL group was 1 
(1–2), while in control group, it was 0 (0–1). The Lund–Mackay score 
were significantly higher in the CLL group than in the control group 
(p=0.004). Fourteen patients had sinusitis at the different locations, 
while the most common diagnosis was maxillary sinusitis (n=8) in the 
CLL group (Table 3). In the control group, 6 patients had localized 
sinusitis. This difference was statistically significant (p=0.27).
Discussion
Chronic lymphocytic leukemia is the most common adult leukemia. 
Majority of the cases involve asymptomatic patients diagnosed at 
routine blood examination (16). Some of the patients apply to the 
hospital with enlargement of splenic and lymphatic nodes, anorex-
ia, and weight loss. If the patients are asymptomatic, they may not 
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Table 1. Baseline characteristics of the CLL group
Blood profile Mean±sd
Hemoglobin 11,860±3,927
Hematocrit 36,335±11,953
Leukocyte 44,779±34,096
Neutrophil 6096,500±2900,165
Lymphocyte 37,136±32,924
Platelets 237,000±88,321
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be treated (16). In our study, the CLL group consisted of early-stage 
untreated patients. The baseline properties of the patients are given 
in Table 1.
Chronic lymphocytic leukemia involvement of paranasal sinuses is 
extremely rare. A few studies have been reported in the literature. 
In two of them, leukemic infiltration of the nasolacrimal duct was 
identified. In one of the studies, sinusitis findings were also pres-
ent (13, 14). Johnston et al. have determined leukemic infiltration in 
the histopathological examination of patients operated for chronic 
pansinusitis (2). The common characteristic of these patients is the 
sinusitis symptoms arising out of obstruction secondary to mucosal 
leukemic infiltration. In our study, nasal leukemic infiltration was not 
determined in any patient. Although rarely encountered, otolaryn-
gologists should be vigilant for mucosal leukemic infiltration, espe-
cially in patients with CRS findings.
The relationship between CLL and paranasal sinuses is not clearly 
identified in the literature, and 25%–-50% of CLL patients lose their 
lives because of infections. Some of these infections are respiratory 
tract infections. In these patients, there may be different low per-
centages of IgG, IgA, and IgM, and they may be prone to infections 
because of hypogammaglobulinanemia (17). The partial disruption 
of mucosal immunity also makes these patients prone to respiratory 
tract infections. It is not surprising to anticipate an increase in infec-
tions, especially during the chemotherapy treatment. Furthermore, 
in advanced-stage CLL patients, fungal and viral infection incidences 
increase (2).
Although in our study, the CLL group consisted of early-stage untreat-
ed patients, the incidence of rhinosinusitis was significantly higher 
than that in the control group. However, sinusitis findings were local. 
Although mostly maxillary sinusitis were observed in paranasal sinus 
computed tomography (n=7), isolated ethmoidal findings were iden-
tified in 4 patients, isolated sphenoid sinusitis in 2 patients, and eth-
moidal and maxillary sinusitis together in 1 patient (Figure 1). These 
findings prove that CLL patients, even at the early stage, are prone to 
upper respiratory tract infections. CLL patients with a weak immune 
system appear to have a high risk potential for upper respiratory tract 
infections and the complications likely to follow.
Recent studies have found out that NF-κB exists in almost all types 
of cells and is in the inactive form depending on the specific inhib-
itors in the cytoplasm. Extracellular stimulants, including bacteria, 
viruses, growth factors, chemotherapeutic agents, ionizing radiation, 
oncogenes, carcinogens, interleukins, lipopolysaccharides, immuno-
globulins, reactive oxygen species, and various psychological, phys-
iological, and oxidative stress stimulants, activate NF-κB molecules. 
Activated NF-κB controls the gene expression related to cell growth, 
differentiation, cytokine production, hematopoiesis, transformation, 
apoptosis, proliferation, immunity, invasion, angiogenesis, and me-
tastasis. The nuclear translocation and activation of NF-κB plays a key 
role in the inflammatory response, particularly because it induces the 
transcription of proinflammatory genes (18-20).
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Table 2. NF-κB and TNF-α staining scores of the groups
                          NF-κB  p value                      TNF-α  p value
Staining scores 0 1  0 1
CLL group 4 (20%) 16 (80%) 0.716 17 (85%) 3 (15%) 1.000 
n(%)
Control group 6 (30%) 14 (70%)  18 (90%) 2 (10%) 
n(%)
TNF-α: Tumor necrosis factor, NF-kB: Nuclear factor-ĸB. 
0: staining <5%, 1: staining between 5%–10%.
Table 3. Diagnoses and Lund–Mackay scores of CLL patients
Patients Lund-Mackay Score Diagnoses
1 2 Maxillary sinusitis
2 2 Maxillary sinusitis
3 1 Maxillary sinusitis
4 2 Maxillary sinusitis
5 0 -
6 2 Maxillary sinusitis
7 1 Maxillary sinus retention cyst
8 2 Maxillary sinusitis
9 1 Osteoma in ethmoid sinus
10 4 Ethmoidal sinusitis
11 1 Sphenoidal sinusitis
12 1 Ethmoidal sinusitis
13 3 Maxillary sinusitis
14 0 -
15 1 Ethmoidal sinusitis
16 6 Maxillary and ethmoidal sinusitis
17 1 Maxillary sinus retention cyst
18 1 Ethmoidal sinusitis
19 1 Maxillary sinus retention cyst
20 1 Sphenoidal sinusitis
Figure 1. Maxillary and ethmoidal sinusitis are seen in the coronal 
section of paranasal CT
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TNF plays a key role in local inflammatory and immune response 
by inducing the expression of inflammatory cytokines (7). Epithelial 
damage, desensitization of odorant-induced signaling, and apop-
totic loss of olfactory neurons are mainly associated with increased 
TNF-α production in the subepithelial layer of CRS. TNF-α can also 
have adverse effects on the respiratory mucosa, causing ciliated cell 
loss, epithelial metaplasia, and further accumulation of inflammato-
ry cells in the subepithelial layer (21). In recent studies, it has been 
demonstrated that NF-kB and TNF-α ratios that have a role in the in-
flammatory pathway increase in patients with CRS (21, 22). In addi-
tion, the function of T regulatory cells could be correlated with levels 
of TNF-α, and TNF-α may increase in patients with CLL (23). In our 
study, we aimed at assessing the paranasal sinuses in patients with 
CLL. For this purpose, we compared NF-kB and TNF-α expression in 
the concha mucosa of CLL patients, which play a role in the inflam-
matory response, with the control group. However, we did not find 
any significant difference between the two groups with respect to 
these two mediators. This finding may demonstrate that the parana-
sal sinus mucosa of early-stage CLL patients is not different from that 
of healthy individuals and there is no inflammatory process.
Conclusion
As a result, early-stage CLL patients tend to have paranasal sinus in-
fections. This study suggests that it is important for these patients to 
be followed-up by an otolaryngologist for rhinosinusitis and associ-
ated complications. However, in the nasal mucosa of these patients, 
no increase in NF-kB and TNF-α expression, which have a role in the 
inflammatory pathway, was determined. Therefore, in early-stage 
CLL patients, a NF-kB- and TNF-α-mediated inflammatory process in-
volving the paranasal sinuses may not be unexpected.
Ethics Committee Approval: Ethics committee approval was received for 
this study from the Ethics Committee of Faculty of Medicine (2014/283). 
Informed Consent: Written informed consent was obtained from relatives of 
the patient who participated in this study.
Peer-review: Externally peer-reviewed.
Author Contributions: Concept - C.G., İ.Y.; Design - İ.Y.; Supervision - İ.Y.; 
Funding - İ.M.; Data Collection and/or Processing - İ.M., A.T., N.A.; Literature 
Review - A.T.; Writing - C.G.; Critical Review - İ.M.; Other - İ.M., C.G., İ.Y.
Conflict of Interest: No conflict of interest was declared by the authors.
Financial Disclosure: The authors declared that this study has received no 
financial support.
Etik Komite Onayı: Bu çalışma için etik komite onayı alınmıştır.
Hasta Onamı: Yazılı hasta onamı bu çalışmaya katılan hastadan alınmıştır. 
Hakem değerlendirmesi: Dış bağımsız.
Yazar Katkıları: Fikir - C.G., İ.Y.; Tasarım - İ.Y.; Denetleme - İ.Y.; Kaynaklar - İ.M.; 
Veri toplanması ve/veya işlemesi - İ.M., A.T., N.A; Literatur taraması - A.T.; Yazıyı 
yazan - C.G.; Eleştirel İnceleme - İ.M.; Diğer - İ.M., C.G., İ.Y.
Çıkar Çatışması: Yazarlar çıkar çatışması bildirmemişlerdir.
Finansal Destek: Yazarlar bu çalışma için finansal destek almadıklarını beyan 
etmişlerdir.
References
1. Furman RR, Asgary Z, Mascarenhas JO, Liou HC, Schattner EJ. Modulation 
of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B 
cells. J Immunol 2000; 164: 2200-06. [CrossRef]
2. Johnston R, Altman KW, Gartenhaus RB. Chronic lymphocytic leukemia 
manifesting in the paranasal sinuses. Otolaryngol Head Neck Surg 2002; 
127: 582-4. [CrossRef]
3. Pagedar NA, Halfdanarson TR, Karnell LH, Hoffman HT, Funk GF. Upper 
aerodigestive tract cancer in patients with chronic lymphocytic leuke-
mia: incidence, stage, and outcome. Arch Otolaryngol Head Neck Surg 
2012; 138: 1171-5. [CrossRef]
4. Richmond A. Nf-kappa B, chemokine gene transcription and tumour 
growth. Nat Rev Immunol 2002; 2: 664-74. [CrossRef]
5. Turco MC, Romano MF, Petrella A, Bisogni R, Tassone P, Venuta S. NF-κB/
Rel-mediated regulation of apoptosis in hematologic malignancies and 
normal hematopoietic progenitors. Leukemia 2004;18:11-7. [CrossRef]
6. Gasparini C, Celeghini C, Monasta L, Zauli G. NF-κB pathways in hemato-
logical malignancies. Cell Mol Life Sci 2014;71:2083-02. [CrossRef]
7. Batikhan H, Gokcan MK, Beder E, Akar N, Ozturk A, Gerceker M. Associ-
ation of the tumor necrosis factor-alpha -308 G/A polymorphism with 
nasal polyposis. Eur Arch Otorhinolaryngol 2010;267:903-8. [CrossRef]
8. Ohori J, Ushikai M, Sun D, et al. TNF-alpha upregulates VCAM-1 and 
NF-kappaB in fibroblasts from nasal polyps. Auris Nasus Larynx 2007; 34: 
177-83. [CrossRef]
9. Wang Z, Zhang Q, Li Y, Li P, Zhang G, Li Y. Involvement of mitogen-acti-
vated protein kinases and nuclear factor kappa B pathways in signaling 
COX-2 expression in chronic rhinosinusitis. Inflamm Res 2009; 58: 649-58. 
[CrossRef]
10. Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach EM, 
Lipsky PE. TNF downmodulates the function of human CD4+CD25hi 
T-regulatory cells. Blood 2006; 108: 253-61. [CrossRef]
11. Wang SZ, Ma FM, Zhao JD. Expressions of nuclear factor-kappa B p50 and 
p65 and their significance in the up-regulation of intercellular cell adhe-
sion molecule-1 mRNA in the nasal mucosa of allergic rhinitis patients. 
Eur Arch Otorhinolaryngol 2013; 270: 1329-34. [CrossRef]
12. Pagedar NA, Halfdanarson TR, Karnell LH, Hoffman HT, Funk GF. Upper 
aerodigestive tract cancer in patients with chronic lymphocytic leuke-
mia: incidence, stage, and outcome. Arch Otolaryngol Head Neck Surg 
2012; 138: 1171-5. [CrossRef]
13. Wong RJ, Gliklich RE, Rubin PA, Goodman M. Bilateral nasolacrimal duct 
obstruction managed with endoscopic techniques. Arch Otolaryng 
Head Neck Surg 1998; 124: 703-6. [CrossRef]
14. Munro S, Brownstein S, Jordan DR, Mcleish W. Nasolacrimal obstruction 
in two patients with chronic lymphocytic leukemia.Can J Opthalmol 
1994; 29: 137-40.
15. Lund VJ, Mackay IS. Staging in rhinosinusitis. Rhinology 1993; 31: 183-4.
16. Rozman C, Montserrat E. Chronic lymphocytic leukemia. N Engl J Med 
1995; 333: 1052-7. [CrossRef]
17. Morrison VA. The infectious complications of chronic lymphocytic leuke-
mia. Semin Oncol 1998; 25: 98-106.
18. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries 
and insights. Annu Rev Immunol 1996; 14: 649-83. [CrossRef]
19. Li Q, Verma IM. NF-kB regulation in the immun system. Nat Rev Immunol 
2002; 2: 725-34. [CrossRef]
20. Gasparini C, Celeghini C, Monasta L, Zauli G. NF-κB pathways in hemato-
logical malignancies. Cell Mol Life Sci 2014; 71: 2083-102. [CrossRef]
21. Karosi T, Csomor P, Sziklai I. Tumor necrosis factor-α receptor expression 
correlates with mucosal changes and biofilm presence in chronic rhinosi-
nusitis with nasal polyposis. Laryngoscope 2012; 122: 504-10. [CrossRef]
22. Valera FC, Umezawa K, Brassesco MS, et al. Suppression of inflammatory 
cytokine secretion by an NF-ĸB inhibitor DHMEQ in nasal polyps fibro-
blasts. Cell Physiol Biochem 2012; 30: 13-22. [CrossRef]
23. Ferrajoli A, Keating MJ, Manshouri T, et al. The clinical significance of tu-
mor necrosis factor-alpha plasma level in patients having chronic lym-
phocytic leukemia. Blood 2002; 100: 1215-9.
12
Günel et al. Paranasal Manifestations of CLL Meandros Med Dent J 2015; 16(1): 9-12
